The Invention relates to the compound N - (2 - [4 - [2 - (4 - amino - 4 - methyl - 2 - chlorine - pyrimidin-5-yl 2-piperidyl) ethyl] - 1 - 1 - methyl - 2 - oxo - ethyl] ciclopropanocarboxamida, able to inhibit Goat. This Compound is useful in the treatment of Type 2 Diabetes and obesity. It also relates to a Pharmaceutical Composition and a method for treating Type 2 Diabetes and obesityLa invencion se refiere al compuesto N-2-[4-[2-(4-Amino-6-cloro-2-metil-pirimidin-5-il)etil-1-piperidil]-1-metil-2-oxo-etil]ciclopropanocarboxamida , capaz de inhibir a GOAT. Dicho compuesto es util en el tratamiento de diabetes tipo 2 y la obesidad. Tambien se refiere a una composicion farmaceutica y un metodo para tratar diabetes tipo 2 y la obesidad
